Interindividual and Intraindividual Responses to PCSK9 Inhibition

JAMA Cardiol. 2019 Jun 1;4(6):600. doi: 10.1001/jamacardio.2019.1194.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • Cholesterol
  • Humans
  • Lipoproteins, LDL*
  • Proprotein Convertase 9*

Substances

  • Antibodies, Monoclonal, Humanized
  • Lipoproteins, LDL
  • Cholesterol
  • PCSK9 protein, human
  • Proprotein Convertase 9
  • evolocumab